Major depressive disorder, generalised anxiety disorder, and their comorbidity: Associations with cortisol in the Vietnam Experience Study

Psychoneuroendocrinology

Volumn 36, Issue 5, 2011, Pages 682-690

  Phillips, Anna C ^a   Batty, G David ^a,b,c   Gale, Catharine R ^c   Lord, Janet M ^a   Arlt, Wiebke ^a   Carroll, Douglas ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Comorbidity; Cortisol; Dehydroepiandrosterone sulphate; Generalised anxiety disorder; Major depressive disorder

Indexed keywords

HYDROCORTISONE; PRASTERONE SULFATE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARMY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENERALIZED ANXIETY DISORDER; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTERVIEW; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL EXAMINATION; OCCUPATION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UNITED STATES; VIET NAM;

ADULT; ALGORITHMS; ANXIETY DISORDERS; COMBAT DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES; VETERANS; VIETNAM CONFLICT;

EID: 79955522700     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.09.011     Document Type: Article

References (84)

1. Arlt W., Haas J., Callies F., Reincke M., Hubler D., Oettel M., Ernst M., Schulte H.M., Allolio B. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J. Clin. Endocrinol. Metab. 1999, 84:2170-2176.
2. Arlt W., Justl H.G., Callies F., Reincke M., Hubler D., Oettel M., Ernst M., Schulte H.M., Allolio B. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J. Clin. Endocrinol. Metab. 1998, 83:1928-1934.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1980, American Psychiatric Association, Washington, DC. 3rd. ed.
4. Bauer M.E. Stress, glucocorticoids and ageing of the immune system. Stress 2005, 8:69-83.
5. Berr C., Lafont S., Debuire B., Dartigues J.F., Baulieu E.E. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:13410-13415.
6. Boscarino J.A. Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: findings and clinical implications. J. Consult. Clin. Psychol. 1996, 64:191-201.
7. Boscarino J.A. Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies. Ann. N Y Acad. Sci. 2004, 1032:141-153.
8. Breslau N., Davis G.C., Peterson E.L., Schultz L.R. A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection. Biol. Psychiatry 2000, 48:902-909.
9. Brown T.A., Campbell L.A., Lehman C.L., Grisham J.R., Mancill R.B. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J. Abnormal Psychol. 2001, 110:585-599.
10. Buford T.W., Willoughby D.S. Impact of DHEA(S) and cortisol on immune function in aging: a brief review. Appl. Physiol. Nutr. Metab. 2008, 33:429-433.
11. Burke H.M., Davis M.C., Otte C., Mohr D.C. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 2005, 30:846-856.
12. Butcher S.K., Killampalli V., Lascelles D., Wang K., Alpar E.K., Lord J.M. Raised cortisol:DHEAS ratios in the elderly after injury: potential impact upon neutrophil function and immunity. Aging Cell 2005, 4:319-324.
13. Campbell D.G., Felker B.L., Liu C.F., Yano E.M., Kirchner J.E., Chan D., Rubenstein L.V., Chaney E.F. Prevalence of depression-PTSD comorbidity: implications for clinical practice guidelines and primary care-based interventions. J. Gen. Intern. Med. 2007, 22:711-718.
14. Checkley S. The neuroendocrinology of depression and chronic stress. Br. Med. Bull. 1996, 52:597-617.
15. de Kloet C., Vermetten E., Lentjes E., Geuze E., van Pelt J., Manuel R., Heijnen C., Westenberg H. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder. Psychoneuroendocrinology 2008, 33:313-320.
16. Decker S.A. Low salivary cortisol and elevated depressive affect among rural men in Botswana: reliability and validity of laboratory results. J. Physiol. Anthropol. 2006, 25:91-101.
17. DeRubeis R.J., Hollon S.D., Amsterdam J.D., Shelton R.C., Young P.R., Salomon R.M., O'Reardon J.P., Lovett M.L., Gladis M.M., Brown L.L., Gallop R. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch. Gen. Psychiatry 2005, 62:409-416.
18. Deuschle M., Schweiger U., Weber B., Gotthardt U., Korner A., Schmider J., Standhardt H., Lammers C.H., Heuser I. Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls. J. Clin. Endocrinol. Metab. 1997, 82:234-238.
19. Dinan T.G. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br. J. Psychiatry 1994, 164:365-371.
20. Ehlert U., Gaab J., Heinrichs M. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus-pituitary-adrenal axis. Biol. Psychol. 2001, 57:141-152.
21. Engeland C.G., Cacioppo J.T., Bosch J.A., Marucha P.T. Oral wound healing is delayed in the aged and in women. Brain Behav. Immun. 2003, 17:173.
22. Finckh A., Berner I.C., Aubry-Rozier B., So A.K. A randomized controlled trial of dehydroepiandrosterone in postmenopausal women with fibromyalgia. J. Rheumatol. 2005, 32:1336-1340.
23. Foy D.W., Carroll E.M., Donahoe C.P. Etiological factors in the development of PTSD in clinical samples of Vietnam combat veterans. J. Clin. Psychol. 1987, 43:17-27.
24. Gaudiano B.A., Zimmerman M. Does comorbid posttraumatic stress disorder affect the severity and course of psychotic major depressive disorder?. J. Clin. Psychiatry 2010, 71:442-450.
25. Gaylord K.M. The psychosocial effects of combat: the frequently unseen injury. Crit. Care Nurs. Clin. North Am. 2006, 18:349-357.
26. Goodyer I.M., Herbert J., Altham P.M., Pearson J., Secher S.M., Shiers H.M. Adrenal secretion during major depression in 8- to 16-year-olds, I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol. Med. 1996, 26:245-256.
27. Hazeldine J., Arlt W., Lord J.M. Dehydroepiandrosterone as a regulator of immune cell function. J. Steroid Biochem. Mol. Biol. 2010, 120:127-136.
28. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
29. Heim C., Newport D.J., Mletzko T., Miller A.H., Nemeroff C.B. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 2008, 33:693-710.
30. Heuser I., Deuschle M., Luppa P., Schweiger U., Standhardt H., Weber B. Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients. J. Clin. Endocrinol. Metab. 1998, 83:3130-3133.
31. Hoge C.W., Auchterlonie J.L., Milliken C.S. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA 2006, 295:1023-1032.
32. Hoge C.W., Castro C.A., Messer S.C., McGurk D., Cotting D.I., Koffman R.L. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New Engl. J. Med. 2004, 351:13-22.
33. Holsboer F., Lauer C.J., Schreiber W., Krieg J.C. Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology 1995, 62:340-347.
34. Hood, S.D., Melichar, J.K., Taylor, L.G., Kalk, N., Edwards, T.R., Hince, D.A., Lenox-Smith, A., Lingford-Hughes, A.R., Nutt, D.J., 2010. Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge. J. Psychopharmacol. DOI: 0269881109359099[pii]10.1177/0269881109359099 [epub ahead of print].
35. Jefferies W.M. Cortisol and immunity. Med. Hypotheses 1991, 34:198-208.
36. Kanter E.D., Wilkinson C.W., Radant A.D., Petrie E.C., Dobie D.J., McFall M.E., Peskind E.R., Raskind M.A. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder. Biol. Psychiatry 2001, 50:238-245.
37. Kara S., Yazici K.M., Gulec C., Unsal I. Mixed anxiety-depressive disorder and major depressive disorder: comparison of the severity of illness and biological variables. Psychiatry Res. 2000, 94:59-66.
38. Kathol R.G., Anton R., Noyes R., Gehris T. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder. Biol. Psychiatry 1989, 25:873-878.
39. Kellner M., Muhtz C., Peter F., Dunker S., Wiedemann K., Yassouridis A. Increased DHEA and DHEA-S plasma levels in patients with post-traumatic stress disorder and a history of childhood abuse. J. Psychiatr. Res. 2010, 44:215-219.
40. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:593-602.
41. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch. Gen. Psychiatry 2005, 62:617-627.
42. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:1048-1060.
43. Lesch K.P., Laux G., Schulte H.M., Pfuller H., Beckmann H. Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder. Psychiatry Res. 1988, 24:25-34.
44. Mantella R.C., Butters M.A., Amico J.A., Mazumdar S., Rollman B.L., Begley A.E., Reynolds C.F., Lenze E.J. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 2008, 33:773-781.
45. Mason J.W., Wang S., Yehuda R., Riney S., Charney D.S., Southwick S.M. Psychogenic lowering of urinary cortisol levels linked to increased emotional numbing and a shame-depressive syndrome in combat-related posttraumatic stress disorder. Psychosom. Med. 2001, 63:387-401.
46. McEwen B.S. Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 2000, 22:108-124.
47. Michael A., Jenaway A., Paykel E.S., Herbert J. Altered salivary dehydroepiandrosterone levels in major depression in adults. Biol. Psychiatry 2000, 48:989-995.
48. Muhtz C., Wester M., Yassouridis A., Wiedemann K., Kellner M. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD-first preliminary results. J. Psychiatr. Res. 2008, 42:689-693.
49. O'Donnell C., Wolffsohn J.S. Grading of corneal transparency. Cont Lens Anterior Eye 2004, 27:161-170.
50. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 1984, 59:551-555.
51. Peeters F., Nicolson N.A., Berkhof J. Levels and variability of daily life cortisol secretion in major depression. Psychiatr. Res. 2004, 126:1-13.
52. Phillips A.C., Batty G.D., Gale C.R., Deary I.J., Osborn D., MacIntyre K., Carroll D. Generalised anxiety disorder, major depressive disorder, and their comorbidity as predictors of all-cause and cardiovascular mortality: the Vietnam Experience Study. Psychosom. Med. 2009, 71:395-403.
53. Phillips A.C., Carroll D., Burns V.E., Drayson M. Neuroticism, cortisol reactivity, and antibody response to vaccination. Psychophysiology 2005, 42:232-238.
54. Phillips A.C., Carroll D., Gale C.R., Lord J.M., Arlt W., Batty G.D. Cortisol, DHEAS, their ratio and the metabolic syndrome: evidence from the Vietnam experience study. Eur. J. Endocrinol. 2010, 162:919-923.
55. Pico-Alfonso M.A., Garcia-Linares M.I., Celda-Navarro N., Herbert J., Martinez M. Changes in cortisol and dehydroepiandrosterone in women victims of physical and psychological intimate partner violence. Biol. Psychiatry 2004, 56:233-240.
56. Porter R.J., Gallagher P., Watson S., Smith M.S., Young A.H. Elevated prolactin responses to l-tryptophan infusion in medication-free depressed patients. Psychopharmacology 2003, 169:77-83.
57. Posener J.A., Charles D., Veldhuis J.D., Province M.A., Williams G.H., Schatzberg A.F. Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder. Psychoneuroendocrinology 2004, 29:1129-1137.
58. Prince M., Patel V., Saxena S., Maj M., Maselko J., Phillips M.R., Rahman A. No health without mental health. Lancet 2007, 370:859-877.
59. Radford D.J., Wang K., McNelis J.C., Taylor A.E., Hechenberger G., Hofmann J., Chahal H., Arlt W., Lord J.M. Dehdydroepiandrosterone Sulfate Directly Activates Protein Kinase C-{beta} to Increase Human Neutrophil Superoxide Generation. Mol. Endocrinol. 2010, 24:813-821.
60. Reeves R.R., Parker J.D., Konkle-Parker D.J. War-related mental health problems of today's veterans: new clinical awareness. J. Psychosoc. Nurs. Ment. Health Serv. 2005, 43:18-28.
61. Resnick H.S., Kilpatrick D.G., Dansky B.S., Saunders B.E., Best C.L. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J. Consult. Clin. Psychol. 1993, 61:984-991.
62. Robins L., Helzer J., Cottler L. Diagnostic Interview Schedule (version III-A) Training Manual 1987, Veterans Administration, St Louis.
63. Sacco M., Valenti G., Corvi Mora P., Wu F.C., Ray D.W. DHEA, a selective glucocorticoid receptor antagonist: its role in immune system regulation and metabolism. J. Endocrinol. Invest. 2002, 25:81-82.
64. Schatzberg A.F., Rothschild A.J., Langlais P.J., Bird E.D., Cole J.O. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J. Psychiatr. Res. 1985, 19:57-64.
65. Sondergaard H.P., Hansson L.O., Theorell T. Elevated blood levels of dehydroepiandrosterone sulphate vary with symptom load in posttraumatic stress disorder: findings from a longitudinal study of refugees in Sweden. Psychother. Psychosom. 2002, 71:298-303.
66. Spivak B., Maayan R., Kotler M., Mester R., Gil-Ad I., Shtaif B., Weizman A. Elevated circulatory level of GABA(A)-antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychol. Med. 2000, 30:1227-1231.
67. Strous R.D., Maayan R., Lapidus R., Stryjer R., Lustig M., Kotler M., Weizman A. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch. Gen. Psychiatry 2003, 60:133-141.
68. Tafet G.E., Feder D.J., Abulafia D.P., Roffman S.S. Regulation of hypothalamic-pituitary-adrenal activity in response to cognitive therapy in patients with generalized anxiety disorder. Cogn. Affect. Behav. Neurosci. 2005, 5:37-40.
69. The Centers for Disease Control Vietnam Experience Study Health status of Vietnam veterans. I. Psychosocial characteristics. JAMA 1988, 259:2701-2707.
70. The Centers for Disease Control Vietnam Experience Study Health status of Vietnam veterans. II. Physical Health. JAMA 1988, 259:2708-2714.
71. The Centers for Disease Control Vietnam Experience Study Health Status of Vietnam veterans. III: Medical Examinations 1989, Centers for Disease Control, Atlanta.
72. Thomson F., Craighead M. Innovative approaches for the treatment of depression: targeting the HPA axis. Neurochem. Res. 2008, 33:691-707.
73. Vythilingam M., Gill J.M., Luckenbaugh D.A., Gold P.W., Collin C., Bonne O., Plumb K., Polignano E., West K., Charney D. Low early morning plasma cortisol in posttraumatic stress disorder is associated with co-morbid depression but not with enhanced glucocorticoid feedback inhibition. Psychoneuroendocrinology 2010, 35:442-450.
74. Vythilingam M., Lawley M., Collin C., Bonne O., Agarwal R., Hadd K., Charney D.S., Grillon C. Hydrocortisone impairs hippocampal-dependent trace eyeblink conditioning in post-traumatic stress disorder. Neuropsychopharmacology 2006, 31:182-188.
75. Vythilingam M., Vermetten E., Anderson G.M., Luckenbaugh D., Anderson E.R., Snow J., Staib L.H., Charney D.S., Bremner J.D. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol. Psychiatry 2004, 56:101-112.
76. Wodarz N., Rupprecht R., Kornhuber J., Schmitz B., Wild K., Riederer P. Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder. J. Affect. Disord. 1992, 25:31-38.
77. World Health Organisation International Statistical Classification of Diseases and Related Health Problems (10th Revision) 1992-1994, WHO, Geneva.
78. Yehuda R., Kahana B., Binder-Brynes K., Southwick S.M., Mason J.W., Giller E.L. Low urinary cortisol excretion in Holocaust survivors with posttraumatic stress disorder. Am. J. Psychiatry 1995, 152:982-986.
79. Yehuda R., Lowy M.T., Southwick S.M., Shaffer D., Giller E.L. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am. J. Psychiatry 1991, 148:499-504.
80. Yehuda R., Southwick S.M., Nussbaum G., Wahby V., Giller E.L., Mason J.W. Low urinary cortisol excretion in patients with posttraumatic stress disorder. J. Nerv. Ment. Dis. 1990, 178:366-369.
81. Yehuda R., Teicher M.H., Trestman R.L., Levengood R.A., Siever L.J. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry 1996, 40:79-88.
82. Young A.H., Gallagher P., Porter R.J. Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am. J. Psychiatry 2002, 159:1237-1239.
83. Young E.A. Sex differences and the HPA axis: implications for psychiatric disease. J. Gend. Specif. Med. 1998, 1:21-27.
84. Young E.A., Kotun J., Haskett R.F., Grunhaus L., Greden J.F., Watson S.J., Akil H. Dissociation between pituitary and adrenal suppression to dexamethasone in depression. Arch. Gen. Psychiatry 1993, 50:395-403.